Biocompatibles International plc
This article was originally published in The Gray Sheet
Executive Summary
Third and final PMA module is submitted to FDA for the BiodivYsio stent, the firm says Feb. 28. Upon approval, the stent will be distributed in the U.S. by Abbott (1"The Gray Sheet" Nov. 29, In Brief)